CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 13, 2004--POZEN Inc.
(NASDAQ: POZN), announced today that it will release third quarter
results on October 27, 2004, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time with a discussion by POZEN management of the earnings and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The
third quarter earnings release can be accessed in the News section of
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN has
development and commercial alliances with GlaxoSmithKline, Xcel
Pharmaceuticals, and Nycomed. The company's common stock is traded on
The Nasdaq Stock Market under the symbol "POZN". For detailed company
information, including copies of this and other press releases, see
POZEN's website: www.pozen.com.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044